Role of WDHD1 in Human Papillomavirus-Mediated Oncogenesis Identified by Transcriptional Profiling of E7-Expressing Cells.
The E7 oncoprotein of the high-risk human papillomavirus (HPV) plays a major role in HPV-induced carcinogenesis. E7 abrogates the G1 cell cycle checkpoint and induces genomic instability, but the mechanism is not fully understood. In this study, we performed RNA sequencing (RNA-seq) to characterize the transcriptional profile of keratinocytes expressing HPV 16 (HPV-16) E7. At the transcriptome level, 236 genes were differentially expressed between E7 and vector control cells. A subset of the differentially expressed genes, most of them novel to E7-expressing cells, was further confirmed by real-time PCR. Of interest, the activities of multiple transcription factors were altered in E7-expressing cells. Through bioinformatics analysis, pathways altered in E7-expressing cells were investigated. The upregulated genes were enriched in cell cycle and DNA replication, as well as in the DNA metabolic process, transcription, DNA damage, DNA repair, and nucleotide metabolism. Specifically, we focused our studies on the gene encoding WDHD1 (WD repeat and high mobility group [HMG]-box DNA-binding protein), one of the genes that was upregulated in E7-expressing cells. WDHD1 is a component of the replisome that regulates DNA replication. Recent studies suggest that WDHD1 may also function as a DNA replication initiation factor as well as a G1 checkpoint regulator. We found that in E7-expressing cells, the steady-state level of WDHD1 protein was increased along with the half-life. Moreover, downregulation of WDHD1 reduced E7-induced G1 checkpoint abrogation and rereplication, demonstrating a novel function for WDHD1. These studies shed light on mechanisms by which HPV induces genomic instability and have therapeutic implications.



The high-risk HPV types induce cervical cancer and encode an E7 oncoprotein that plays a major role in HPV-induced carcinogenesis. However, the mechanism by which E7 induces carcinogenesis is not fully understood; specific anti-HPV agents are not available. In this study, we performed RNA-seq to characterize transcriptional profiling of keratinocytes expressing HPV-16 E7 and identified more than 200 genes that were differentially expressed between E7 and vector control cells. Through bioinformatics analysis, pathways altered in E7-expressing cells were identified. Significantly, the WDHD1 gene, one of the genes that is upregulated in E7-expressing cells, was found to play an important role in E7-induced G1 checkpoint abrogation and rereplication. These studies shed light on mechanisms by which HPV induces genomic instability and have therapeutic implications.
The Cancer Research Center, Shandong University School of Medicine, Jinan, Shandong, China.
Yunying
Y
Zhou
The Cancer Research Center, Shandong University School of Medicine, Jinan, Shandong, China.
Qishu
Q
Zhang
Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA.
Ge
G
Gao
The Qilu Hospital, Shandong University School of Medicine, Jinan, Shandong, China.
Xiaoli
X
Zhang
The Cancer Research Center, Shandong University School of Medicine, Jinan, Shandong, China.
Yafei
Y
Liu
The Cancer Research Center, Shandong University School of Medicine, Jinan, Shandong, China.
Shoudao
S
Yuan
Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri, USA xwang@radonc.wustl.edu jxchen@sdu.edu.cn.
Xiaowei
X
Wang
The Cancer Research Center, Shandong University School of Medicine, Jinan, Shandong, China xwang@radonc.wustl.edu jxchen@sdu.edu.cn.
Jason J
JJ
Chen
D063646:Carcinogenesis; D018797:Cell Cycle Proteins / Q000235:genetics / Q000378:metabolism; D019295:Computational Biology; D004249:DNA Damage / Q000235:genetics; D004260:DNA Repair / Q000235:genetics; D004261:DNA Replication / Q000235:genetics; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D059585:G1 Phase Cell Cycle Checkpoints / Q000235:genetics; D020869:Gene Expression Profiling; D042822:Genomic Instability; D006207:Half-Life; D052162:Human papillomavirus 16 / Q000235:genetics / Q000502:physiology*; D006801:Humans; D015603:Keratinocytes / Q000821:virology*; D053858:Metabolic Networks and Pathways / Q000235:genetics; D050725:Papillomavirus E7 Proteins / Q000235:genetics* / Q000378:metabolism; D060888:Real-Time Polymerase Chain Reaction; D017423:Sequence Analysis, RNA; D014157:Transcription Factors / Q000235:genetics
D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D050725:Papillomavirus E7 Proteins; D014157:Transcription Factors; C544202:WDHD1 protein, human; C059731:oncogene protein E7, Human papillomavirus type 16